Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: A phenotypical and functional study

Neuropeptides

Volumn 30, Issue 5, 1996, Pages 456-464

  Brunelleschi, S ^a,c   Guidotto, S ^a   Viano, I ^a   Fantozzi, R ^b   Pozzi, E ^c   Ghio, P ^c   Albera, C ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b Dept Anat Pharmacol Forensic M   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; FREE RADICAL; NEUROKININ A; SUBSTANCE P; SUPEROXIDE; TACHYKININ RECEPTOR AGONIST; THIORPHAN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE; MALE; PRIORITY JOURNAL; SARCOIDOSIS; SMOKING;

NICOTIANA TABACUM;

EID: 0029910139     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90010-4     Document Type: Article

References (38)

1. Thomas R D, Hunninghake G W. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135: 747-760.
2. Geogh B A, Crystal R G. Alveolitis: the key to interstitial lung disorders. Thorax 1982; 37: 1-10.
3. 2 release, alveolitis and disease severity in sarcoidosis. Chest 1993; 103: 832-838.
4. Johnston Jr, R B. Monocytes and macrophages. N Engl J Med 1988; 12: 747-752.
5. Lohmann-Matthes M L, Steinmuller C, Franke-Ulmann G. Pulmonary macrophages. Eur Respir J 1994; 7: 1678-1689.
6. Chanez P, Bousquet J, Couret I et al. Increased levels of hypodense alveolar macrophages in patients with bronchial asthma. Am Rev Respir Dis 1991; 144: 923-930.
7. Kuo H P, Yu C T. Alveolar macrophage subpopulations in patients with active pulmonary tuberculosis. Chest 1993; 104: 1773-1778.
8. Schaberg T, Lauer C, Lode H, Fisher J, Haller H. Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Am Rev Respir Dis 1992; 146: 1287-1293.
9. Sandron D, Reynolds H Y, Laval A N, Venet A, Israel-Biet D, Chretien J. Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients. Eur J Respir Dis 1986; 68: 177-185.
10. Hinman L M, Stevens C, Matthay R A, Gee J B L. Angiotensin convertase activity in human alveolar macrophages: effects of cigarette smoking and sarcoidosis. Science 1979; 205: 202-203.
11. Gupta R G, Sicilian L, Catchatourian R, Beckerman C, Oparil S, Szidon JP. Angiotensin converting enzyme in serum and broncholaveolar lavage in sarcoidosis. Respiration 1982, 43: 153-157
12. Barnes P J, Baraniuk J N, Belvisi M G. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991; 144: 1187-1198.
13. Springall D R, Polak J M, Howard L, Power R F, Krausz T. Persistence of intrinsic neurones and possible changes after extrinsic denervation of human respiratory tract by heart-lung transplantations. Am Rev Respir Dis 1990; 141: 1538-1546.
14. Fluge T, Sprenger P, Henkel E, Fabel H, Wagner T O F. Substance P (SP) and protein content (P) in the bronchoalveolar lavage fluid (BAL) following lun (LTX) and heart-lung transplantation (HLTX). Eur Respir J 1994; 7 (suppl 18): 2955s.
15. Payan D G, Brewster J D, Goetzl E J. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983; 131: 1613-1615.
16. Brunelleschi S, Tarli S, Giotti A, Fantozzi R. Priming effects of mammalian tachykinins on human neutrophils. Life Sci 1991; 48: PL1-PL5.
17. Lotz M, Vaughan J H, Carson D A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241: 1218-1221.
18. 2 receptors. Br J Pharmacol 1990; 100: 417-420.
19. Brunelleschi S, Parenti A, Ceni E, Giotti A, Fantozzi R. Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. Br J Phamacol 1992; 107: 964-969.
20. Albera C, Cappia S, Leonardo E et al. Mycobacterial lung infection and lymphocytes. In: Baggiolini M, Pozzi E, Semenzato G, eds. Neutrophils, Lymphocytes and Lung. Masson, 1990: 277-285.
21. Calvelli T, Denny T N, Paxton H, Gelman R, Kagan I. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993; 14: 702-715.
22. Joos G F, Germonpre P R, Kips J C, Peleman R A, Pawels R A. Sensory neuropeptides and the human lower airways: present state and future directions. Eur Respir J 1994; 7: 1161-1171.
23. Dusser D J, Djokic T D, Borson D B, Nadel J A, Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea-pig. Possible role of free radicals. J Clin Invest 1989; 84: 900-906.
24. Pujol J L, Bousquet J, Grenier J et al. Substance P activation of bronchoalveolar macrophages from asthmatic patients and normal subjects. Clin Exp Allergy 1989; 19: 625-628.
25. 2 receptors. Am J Physiol 1995; 269: L631-L636.
26. Murris-Espin M, Pinelli E, Pipy B, Leophonte P, Didier A. Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production. Allergy 1995; 50: 334-339.
27. Kavelaars A, Broeke D, Jeurissen F et al. Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase, and IL-6 production. J Immunol 1994; 153: 3691-3699.
28. Jeurissen F, Kavelaars A, Korstjens M et al. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase. J Immunol 1994; 152: 2987-2994.
29. Hubbard R C, Ogushi F, Fells G A et al. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of α1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest 1987; 80: 1289-1295.
30. Calhoun W J, Salisbury S M, Chosy L W, Busse W W. Increased alveolar macrophage chemiluminescence and airspace cell superoxide production in active pulmonary sarcoidosis. J Lab Clin Med 1988; 112: 147-156.
31. Pulford K A F, Sipos A, Cordell J L, Stress W P, Mason D Y. Distribution of the CD68 macrophage/myeloid associated antigen. Int J Immunol 1990; 2: 973-980.
32. Komatsu T, Yamamoto M, Shimokata K, Nagura K. Phenotypic characterization of alveolar capillary endothelial cells, alveolar epithelial cells and alveolar macrophages in patients with pulmonary fibrosis, with special reference to MHC class II antigens. Virchows Archiv A Pathol Anat 1989; 415: 79-90.
33. Ziegler-Heitbrock H W L, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunology Today 1993; 14: 121-125.
34. Tomaki M, Ichinose M, Miura M, Kageyama N, Yamauchi H, Shirato K. Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P. Thorax 1996; 51: 199-201.
35. Tomaki M, Ichinose M, Miura M et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995; 151: 613-617
36. Rohrbach M S, Deremee R A. Pulmonary sarcoidosis and serum angiotensin converting enzyme. Mayo Clin Proc 1982; 57: 664-666.
37. Mordelet-Dambrine M S, Stanislas-Leguern G, Huchon G, Baumann F C, Marsac J, Chretien J. Elevation of the bronchoalveolar concentration of angiotensin I converting enzyme in sarcoidosis. Am Rev Respir Dis 1982; 126: 472-475.
38. Valeyre D, Soler P, Clerici C et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis and evolution of the disease. Thorax 1988; 43: 516-524.